Rossari Biotech Ltd - Stock Valuation and Financial Performance

BSE: 543213 | NSE: ROSSARI | Chemicals | Small Cap

Rossari Biotech Share Price

849 15.40 1.85%
as on 08-Oct'24 16:01

DeciZen - make an informed investing decision on Rossari Biotech

Overall Rating
Bole Toh

1. Quality

2. Valuation

Somewhat Undervalued

3. Price Trend

Rossari Biotech stock performance -

mw4me loader
P/E Ratio (CD):
33.80
Market Cap:
4,608.9 Cr.
52-wk low:
657.8
52-wk high:
966

Is Rossari Biotech Ltd an attractive stock to invest in?

1. Is Rossari Biotech Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Rossari Biotech Ltd is a good quality company.

2. Is Rossari Biotech Ltd undervalued or overvalued?

The key valuation ratios of Rossari Biotech Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Rossari Biotech Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Rossari Biotech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Rossari Biotech:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Rossari Biotech Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 10.7%10.3%26.4%40.4%54.4%37.9%28.8%24.4%18.5%18.4%-
Value Creation
Index
-0.2-0.30.91.92.91.71.10.80.30.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1711792332925166007091,4831,6561,8311,910
Sales YoY Gr.-4.4%30.6%25%76.9%16.3%18.2%109.1%11.7%10.6%-
Adj EPS 0.80.73.35.99.512.615.316.318.322.624.7
YoY Gr.--7.9%364.3%81.9%60.1%33.1%21.8%6%12.9%23.1%-
BVPS (₹) 9.710.313.519.525.656.478.3145.7165.3189195.5
Adj Net
Profit
3.73.415.728.645.863.979.689.5101125136
Cash Flow from Ops. 8.125.77.223.671.256.847.829.415243.3-
Debt/CF from Ops. 5.40.93.10.90.11.200.30.52.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 30.1%28.8%37.2%10.6%
Adj EPS 45.8%19%13.8%23.1%
BVPS39.1%49.2%34.1%14.4%
Share Price - - -17% 1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
7.7727.335.84231.122.914.711.812.712.8
Op. Profit
Mgn %
8.6710.415.315.117.517.411.91313.313.4
Net Profit
Mgn %
2.21.96.79.88.910.711.266.16.87.1
Debt to
Equity
0.90.50.30.200.2000.10.1-
Working Cap
Days
15313210710910714016313416618979
Cash Conv.
Cycle
8162424524132946687937

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 37.16%

Net Profit is growing at healthy rate in last 3 years 13.76%

Sales growth is good in last 4 quarters at 17.08%

Return on Equity has declined versus last 3 years average to 12.80%

Latest Financials - Rossari Biotech Ltd.

Standalone Consolidated
TTM EPS (₹) 18.5 24.7
TTM Sales (₹ Cr.) 1,245 1,910
BVPS (₹.) 177.8 195.5
Reserves (₹ Cr.) 972 1,070
P/BV 4.69 4.26
PE 45.00 33.80
From the Market
52 Week Low / High (₹) 657.80 / 966.00
All Time Low / High (₹) 536.10 / 1620.60
Market Cap (₹ Cr.) 4,609
Equity (₹ Cr.) 11.1
Face Value (₹) 2
Industry PE 57.9

Management X-Ray of Rossari Biotech:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Rossari Biotech

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales1711792332925166007091,4831,6561,831
Operating Expenses 1561662092474394955861,3071,4411,587
Manufacturing Costs4463131421384964
Material Costs1231311661973393724621,1081,1711,294
Employee Cost 111214202837426899103
Other Costs 1820232859736193123127
Operating Profit 1513244578105123176215243
Operating Profit Margin (%) 8.5%7.0%10.4%15.3%15.0%17.5%17.3%11.9%13.0%13.3%
Other Income 0011149191414
Interest 5421343132219
Depreciation 5545121723486360
Exceptional Items 0000000000
Profit Before Tax 5519406388107136144178
Tax 11311182327393747
Profit After Tax 43162946658098107131
PAT Margin (%) 2.2%1.9%6.7%9.9%8.8%10.9%11.3%6.6%6.5%7.1%
Adjusted EPS (₹)0.80.73.36.09.412.915.517.719.523.7
Dividend Payout Ratio (%)6%0%0%30%5%4%3%3%3%2%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 475065941242864078029121,044
Share Capital 444441010111111
Reserves 424661901192763967919011,033
Minority Interest0000000000
Debt39222220461006496
Long Term Debt9721134003533
Short Term Debt30152019327002963
Trade Payables1828324010697131186181219
Others Liabilities 1085114980107429415465
Total Liabilities 1141091241662835256451,4171,5721,825

Fixed Assets

Gross Block6738768886122234704743791
Accumulated Depreciation300384312295397158213
Net Fixed Assets383838457494181607585578
CWIP 78810322011647
Investments 00070180365163
Inventories31252435555895190188282
Trade Receivables303147608694144305354425
Cash Equivalents 13216127885212430
Others Assets755859112135225253399
Total Assets 1141091241662835256451,4171,5721,825

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 8267247157482915243
PBT 5519406388107136144178
Adjustment 9766172021558376
Changes in Working Capital -513-14-1111-31-48-112-28-157
Tax Paid -1-1-3-11-20-20-31-50-48-54
Cash Flow From Investing Activity -2-5-6-20-36-190-37-299-181-103
Capex -2-5-6-14-44-76-56-36-31-126
Net Investments 00007-1814-6-14-9
Others 000-71-965-257-13632
Cash Flow From Financing Activity -6-19-2-5-29157-252926116
Net Proceeds from Shares 000001004330244
Net Proceeds from Borrowing 0000-139-34045-12
Interest Paid -5-3-2-1-2-3-4-2-6-16
Dividend Paid 0000-11-3-3-3-3-3
Others -2-170-4-1624-27-52143
Net Cash Flow 020-2623-142232-44
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)8.186.9927.2736.3341.8831.8323.1116.1712.5213.36
ROCE (%)10.710.326.440.3754.437.9328.8124.3718.4818.39
Asset Turnover Ratio1.431.622.062.31.491.221.451.111.08
PAT to CFO Conversion(x)28.670.440.831.540.880.60.31.420.33
Working Capital Days
Receivable Days62626166515461557277
Inventory Days78583836323439354247
Payable Days686566677910090525756

Rossari Biotech Ltd Stock News

Rossari Biotech Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Rossari Biotech on 08-Oct-2024 16:01 is ₹849.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 08-Oct-2024 16:01 the market cap of Rossari Biotech stood at ₹4,608.9.
The latest P/E ratio of Rossari Biotech as of 08-Oct-2024 16:01 is 45.00.
The latest P/B ratio of Rossari Biotech as of 08-Oct-2024 16:01 is 4.69.
The 52-week high of Rossari Biotech is ₹966.0 and the 52-week low is ₹657.8.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Rossari Biotech is ₹1,245 ( Cr.) .

About Rossari Biotech Ltd

The company was initially incorporated as Rossari Labtech on March 6, 2003, as a partnership firm under the Indian Partnership Act, 1932, pursuant to a certificate of registration dated June 22, 2003, issued by the Registrar of Firms, Mumbai. The name of the partnership firm was changed to Rossari Biotech on December 5, 2003 and further the firm converted into a joint stock company on August 10, 2009, under part IX of the Companies Act, 1956 as Rossari Biotech Limited with a certificate of incorporation granted by the Registrar of Companies, Maharashtra at Mumbai (RoC). The company received its certificate of commencement of business on August 13, 2009.

Business area of the company

The company is one of the leading specialty chemicals manufacturing companies in India providing customized solutions to specific industrial and production requirements of its customers primarily in the FMCG, apparel, poultry and animal feed industries through its diversified product portfolio comprising home, personal care and performance chemicals; textile specialty chemicals; and animal health and nutrition products. The company’s business is organized in three main product categories - (i) home, personal care and performance chemicals; (ii) textile specialty chemicals; and (iii) animal health and nutrition products.

The company is the leading manufacturer of acrylic polymers in India and manufactures many products for its customers in the soaps and detergent, paints, inks and coatings, ceramics and tiles, water treatment chemicals and pulp and paper industries. It also manufacture institutional cleaning chemical formulations for hospitality, facility management, airports, corporates, food service, commercial laundry, malls, multiplexes, educational sector, places of worship etc. It is in advanced stages of expanding its home, personal care and performance product portfolio to water treatment formulations, specialty formulation for breweries as well as dairies. Besides, the company provides specialty chemicals for the entire value-chain of the textile industry starting from fiber, yarn to fabric, wet processing and garment processing. The company has also diversified into animal health and nutrition and currently supply poultry feed supplements and additives, pet grooming and pet treats including for weaning, infants and adult pets.

Major Events & Milestones:

  • 2003: The company’s Promoters entered into a partnership firm to start the manufacturers of specialty chemicals and industrial enzymes in India.
  • 2004: Established first manufacturing facility at Silvassa.
  • 2009: Conversion of partnership firm into company.
  • 2009: Incorporation of company.
  • 2009: Obtained recognition for in-house R&D unit from the Department of Scientific and Industrial Research.
  • 2010: Forayed into animal health and nutrition products.
  • 2013: Forayed into HPPC products.
  • 2014: The company’s Promoters entered into a Joint Venture with BUZIL-WERK Wagner GmbH & Co. KG to form Buzil Rossari.
  • 2015: Lease granted by GIDC to company for setting up manufacturing facility at Dahej.
  • 2017: The Food Safety Management System of Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 9001:2015.
  • 2018: Entered into an exclusive purchasing agreement with Hindustan Unilever.
  • 2020: Completion of the Pre-IPO Placement.

Awards & accreditations:

  • 2009: The erstwhile Hon’ble Union Finance Minister Pranab Mukherjee awarded ‘Corp EXCEL 2008– National mSME’ form a list of 27000 companies.
  • 2010: Frost & Sullivan awarded ‘Customer Value Enhancement for Industrial Enzymes Market’.
  • 2011: The Council for Fair Business Practices awarded ‘CFBP – Jamnalal Bajaj Uchit Vyavahar Puraskar for Fair Business Practices’.
  • 2017: The India SME Forum awarded at the India SME 100 Awards for ‘scoring in the top 100 in the overall evaluation of Financial & Non - Financial Parameters amongst 33102 nominations’.
  • 2018: Arvind awarded ‘Star Performer Award 2018’ in the Dye & Chemicals Category.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.